Central Sleep Apnea
31
2
5
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.9%
4 terminated out of 31 trials
81.8%
-4.7% vs benchmark
10%
3 trials in Phase 3/4
33%
6 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (31)
Diagnosis of Sleep-Related Respiratory Disorders in Patients With Narcotic Medications
Natural History of Central and Mixed Sleep Apneas Followed by Maxillomandibular Advancement for Obstructive Sleep Apnea
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV
Managing Opioid Related Sleep Apnea With Acetazolamide
ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.
remedē System Therapy Study
Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF
The IPAd Study: Exploring the Association Between Insomnia and Positive Airway Pressure Adherence in Children
Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Interface Selection for Adaptive Servo Ventilation
Belgian Central Sleep Apnea REgistry
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP
Heated Humidified High Flow Nasal Cannula Oxygen in Obstructive Sleep Apnea in Adolescents
A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.
The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea
Pathophysiological Study of CSA in Adults With pLVEF
Nocturnal Oxygen Needs and Central Sleep Apnea in Patients With Chronic Heart Failure.
Central Sleep Apnea Treated by CO2 Supplied by a Novel Device
Post Approval Study of the remedē System